Form 4 for OSCR Oscar Health, Inc.
Accepted 2024-09-04 00:00:00 ET · period of report 2024-09-01 · accession 0001562180-24-006663 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-09-04 | 2024-09-01 | OSCR | Blackley Richard Scott | CFO | M - OptEx | — | +277.7K | 944.5K | +42% | — |
| DM | 2024-09-04 | 2024-09-03+ | OSCR | Blackley Richard Scott | CFO | S - Sale+OE | $17.82 | -131.9K | 884.2K | -13% | -$2.35M |
| DM | 2024-09-04 | 2024-09-01 | OSCR | Blackley Richard Scott | CFO | M - OptEx | $0.00 | -53.2K | 375.8K | -12% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-09-01 | M | A | 8,652 | — | 953,191 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of Class A common stock. |
| 2 | Common | Class A Common Stock | 2024-09-04 | S | D | 28,257 | $17.85 | 821,332 | D | — | — | (F3) The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards. (F6) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.63 to $18.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. |
| 3 | Common | Class A Common Stock | 2024-09-04 | S | D | 34,624 | $17.46 | 849,589 | D | — | — | (F3) The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards. (F5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.63 to $17.62, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. |
| 4 | Common | Class A Common Stock | 2024-09-01 | M | A | 7,016 | — | 682,458 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of Class A common stock. |
| 5 | Common | Class A Common Stock | 2024-09-01 | M | A | 37,578 | — | 720,036 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of Class A common stock. |
| 6 | Common | Class A Common Stock | 2024-09-01 | M | A | 224,503 | — | 944,539 | D | — | — | (F2) The Issuer previously granted the Reporting Person an award of 244,503 restricted stock units that vested on September 1, 2024, following the Talent & Compensation Committee's determination that the performance condition for the prior fiscal year had been achieved. (F1) Each restricted stock unit represents a contingent right to receive one share of Class A common stock. |
| 7 | Common | Class A Common Stock | 2024-09-03 | S | D | 68,978 | $17.99 | 884,213 | D | — | — | (F3) The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards. (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.66 to $18.40, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected. |
| 8 | Derivative | Restricted Stock Units | 2024-09-01 | M | D | 7,016 | $0.00 | 28,063 | D | — · — to — | 7,016 Class A Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Class A common stock. (F7) The restricted stock units vest in sixteen equal quarterly installments beginning on December 1, 2021. |
| 9 | Derivative | Restricted Stock Units | 2024-09-01 | M | D | 8,652 | $0.00 | 86,525 | D | — · — to — | 8,652 Class A Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Class A common stock. (F9) The restricted stock units vest in twelve equal quarterly installments beginning on June 1, 2024. |
| 10 | Derivative | Restricted Stock Units | 2024-09-01 | M | D | 37,578 | $0.00 | 375,777 | D | — · — to — | 37,578 Class A Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Class A common stock. (F8) The restricted stock units vest in sixteen equal quarterly installments beginning on June 1, 2023. |